Coronavirus infection is on the rise in the country and vaccination is considered to be the biggest weapon against the epidemic.
Mumbai: Coronavirus infection is on the rise in the country and vaccination is considered to be the biggest weapon against the epidemic. The Covaxin and Covishield vaccines are currently being given to people over the age of 18 across the country, but there is ongoing debate about which of these vaccines is more effective. Now the DG of the Indian Council of Medical Research (ICMR). Dr. Balram Bhargava has made a big statement in this regard.
More antibodies from Covishield than Covaxin
The head of the Indian Council of Medical Research (ICMR), Dr. Dr Balram Bhargava has made a shocking claim about antibodies after vaccination with Covaxin and Covishield. “More antibodies are produced after the first dose of covachield vaccine than the first dose of covacin,” he said. (covaxin vs covishield First covaxin dose not as effective as covishield says icmr head balram bhargava)
Antibodies after taking both doses of covacin
According to a report in the Times of India, ICMR chief Dr. Balram Bhargava said, ‘Not enough antibodies are produced after the first dose of covacin, but enough antibodies are produced after the second dose. This is revealed in a new study. At the same time, it is only after the first dose of Covishield that antibodies are produced.
Increased the interval between 2 doses of Covishield
The interval between two doses of Covishield has been increased to 12-18 weeks due to better antibody development in the first dose. At the same time, the four-week interval applied for covaxin has not changed. Speaking about the government’s decision to make a three-month gap mandatory for Covishield, Dr. Balram Bhargava said that after the first dose, the immunity was found to be very good. So the effect of three months interval will look good.
